Clinical Trials Directory

Trials / Unknown

UnknownNCT05077007

Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures

Detailed description

The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures and assess their usefulness as diagnostic biomarkers for AKI and the relationship between the selected RNA based biomarker panel and clinicopathological changes of patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous nephrolithotomyEndoscopic stone Extraction from the kidney by making a puncture and dilate a tract direct into the kidney through muscle wall and renal parenchyma
PROCEDUREExtracorporeal Shock Wave LithotripsyUsing Shock waves from outside the body targeted at a kidney stone causing the stone to fragment. The stones are broken into tiny pieces.

Timeline

Start date
2021-01-01
Primary completion
2022-08-22
Completion
2022-11-01
First posted
2021-10-13
Last updated
2022-02-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05077007. Inclusion in this directory is not an endorsement.

Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers (NCT05077007) · Clinical Trials Directory